These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 28484083)
21. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549 [TBL] [Abstract][Full Text] [Related]
22. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake. Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451 [TBL] [Abstract][Full Text] [Related]
23. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma. Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084 [TBL] [Abstract][Full Text] [Related]
24. The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells. Ren C; Gao C; Li X; Xiong J; Shen H; Wang L; Zhu D; Wu P; Ding W; Wang H Anticancer Agents Med Chem; 2020; 20(17):2125-2135. PubMed ID: 32753022 [TBL] [Abstract][Full Text] [Related]
25. The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy. Hernlund E; Olofsson MH; Fayad W; Fryknäs M; Lesiak-Mieczkowska K; Zhang X; Brnjic S; Schmidt V; D'Arcy P; Sjöblom T; De Milito A; Larsson R; Linder S Eur J Cancer; 2012 Feb; 48(3):396-406. PubMed ID: 22154651 [TBL] [Abstract][Full Text] [Related]
26. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells. Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435 [TBL] [Abstract][Full Text] [Related]
27. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells. Teixeira SF; Guimarães Idos S; Madeira KP; Daltoé RD; Silva IV; Rangel LB J Bras Pneumol; 2013; 39(6):644-9. PubMed ID: 24473757 [TBL] [Abstract][Full Text] [Related]
28. Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer. Zeng F; Tuo Y; Liu D; He M J Obstet Gynaecol Res; 2020 Jun; 46(6):950-954. PubMed ID: 32266759 [TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Dong YB; Yang HL; Elliott MJ; McMasters KM Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154 [TBL] [Abstract][Full Text] [Related]
30. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study. Segovia-Mendoza M; Jurado R; Mir R; Medina LA; Prado-Garcia H; Garcia-Lopez P BMC Cancer; 2015 Jan; 15():21. PubMed ID: 25622528 [TBL] [Abstract][Full Text] [Related]
31. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer. Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378 [TBL] [Abstract][Full Text] [Related]
32. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications. Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802 [TBL] [Abstract][Full Text] [Related]
33. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells. Fang L; Wang H; Zhou L; Yu D Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744 [TBL] [Abstract][Full Text] [Related]
34. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo. Geng X; Xie L; Xing H Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer. Chi RA; van der Watt P; Wei W; Birrer MJ; Leaner VD BMC Cancer; 2021 Feb; 21(1):106. PubMed ID: 33530952 [TBL] [Abstract][Full Text] [Related]
36. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655 [TBL] [Abstract][Full Text] [Related]
37. Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines. Mueller A; Bachmann E; Linnig M; Khillimberger K; Schimanski CC; Galle PR; Moehler M Cancer Chemother Pharmacol; 2012 Jun; 69(6):1601-15. PubMed ID: 22543857 [TBL] [Abstract][Full Text] [Related]
38. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin. Zhang L; Zhang S J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048 [TBL] [Abstract][Full Text] [Related]
39. Tayeh Z; Ofir R Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061495 [TBL] [Abstract][Full Text] [Related]
40. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth. Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]